Simin Hu

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah et al. · New England Journal of Medicine · 2012 · 770 citations · Full text

Medicine, Oncology, Pharmacology +13

Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study

Samuel A. Kocoshis, Russell J. Merritt, Susan Hill et al. · Journal of Parenteral and Enteral Nutrition · 2019 · 151 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +16

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib

Filip Jankú, Albiruni R. Abdul Razak, Ping Chi et al. · Journal of Clinical Oncology · 2020 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase 1 Trial of Oral Ponatinib (AP24534) In Patients with Refractory Chronic Myelogenous Leukemia (CML) and Other Hematologic Malignancies: Emerging Safety and Clinical Response Findings

Jörge E. Cortes, Moshe Talpaz, Dale L. Bixby et al. · Blood · 2010 · 72 citations

Medicine, Hematology, Pharmacology +9

A Phase 1 Trial of Oral AP24534 in Patients with Refractory Chronic Myeloid Leukemia and Other Hematologic Malignancies: First Results of Safety and Clinical Activity against T315I and Resistant Mutations.

Jörge E. Cortes, Moshe Talpaz, Michael W. Deininger et al. · Blood · 2009 · 31 citations

Medicine, Hematology, Pharmacology +9